•   EN

    • NGS SOLUTIONS

    Nextgeneration sequencing (NGS) is a sequencing method to determine the order ofnucleotides which accounts for our genome and is based onmassive parallel sequencing of short fragments.


    NGS has revolutionized the biological science field and it allows to carry outa wide variety of applications and study biological systems. NGS is a cutting-edgetechnology and has become a daily tool for those seeking a proper diagnosis

    and knowledge relation totheir genome.


    NGS ALLOWS:

    • Rapidly sequence whole genomes.
    • Deeply sequence target regions.
    • Utilize RNA sequencing (RNA-Seq) to discover novel RNA variants and splice sites, or quantify mRNAs for gene expression analysis.
    • Analyze epigenetic factors such as genome-wide DNA methylation and DNA-protein interactions.
    • Sequence cancer samples to study rare somatic variants, tumor subclones.
    • Study the human microbiome.
    • Identify novel pathogens.

    Amplexa genetics offers a wide range of next generation sequencing solutions. We offer:

     

    • Whole Genome sequencing or amplification.
      • Whole genome sequencing sequences the entire genome. This can give us information not only about the coding parts of the genome but the entire genome.
    • Exomesequencing.
      • With exome sequencing we sequence the coding part of the genome, it can be used to evaluate variants in the coding part of our genome with a high read depth, which will make it possible to evaluate most genetic variants.
    • Sequencing of panels.
      • With sequencing of panels, only selected genes and parts of the genome are sequenced. This can be used to create panels with ultra-high read depth or to only look a specific areas of our genome, or special genes of interest. At Amplexa Genetics we use panel sequencing for our genes2life, gene4life and focal epilepsy panels.
    • RNA sequencing.
      • RNA sequencing can be used to evaluate our genome when it has been processed from DNA to RNA, this can give an insight into transcriptional and translational changes, which can not be evaluated with DNA sequencing. At Amplexa Genetics we have used RNA-sequencing to evaluate gene-expression of selected genes during a research collaboration.